Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Digestion resistant maltodextrin (DRM), also known as resistant maltodextrin, is a type of soluble dietary fiber that resists digestion in the small intestine and is fermented in the colon. Its use in colitis, particularly ulcerative colitis and Crohn’s disease (both forms of inflammatory bowel disease, IBD), has some scientific support, though the evidence is relatively limited and preliminary.

Several small clinical studies and animal models suggest that DRM can beneficially alter the composition of the gut microbiota, increase the production of short-chain fatty acids (SCFAs) like butyrate, and reduce markers of inflammation in the colon. SCFAs have well-documented anti-inflammatory effects and play a role in maintaining intestinal barrier integrity, which is often compromised in colitis.

A few human studies, including randomized controlled trials, have indicated that DRM supplementation may improve stool consistency, reduce gastrointestinal symptoms, and modulate immune responses in patients with IBD. However, these studies are limited in size and duration. Systematic reviews on prebiotics and IBD often include DRM as one of several fibers with potential benefit, but they also highlight the need for more robust clinical trials.

In summary, while there is some scientific validation for the use of digestion resistant maltodextrin in supporting gut health and potentially alleviating colitis symptoms, the strength of the evidence is modest (rated 2/5), and further research is needed before it can be considered a standard part of colitis treatment.

More about Digestion resistant Maltodextrin
More about Colitis

Other ingredients used for Colitis

Other health conditions supported by Digestion resistant Maltodextrin

Products containing Digestion resistant Maltodextrin